Social determinants of health and treatment decisions in head and neck cancer

Background This study compares select social determinants of health (SDOH) with treatment modality selection and treatment completion in head and neck cancer (HNC) patients, to better understand disparities in health outcomes. Methods A retrospective cohort study of HNC (n = 1428) patients was condu...

Full description

Saved in:
Bibliographic Details
Published inHead & neck Vol. 44; no. 2; pp. 372 - 381
Main Authors Shehan, Jennifer N., Alwani, Tooba, LeClair, Jessica, Mahoney, Taylor F., Agarwal, Pratima, Chaudhry, Salil T., Wang, Judy J., Noordzij, Jacob Pieter, Tracy, Lauren F., Edwards, Heather A., Grillone, Gregory, Salama, Andrew R., Jalisi, Scharukh M., Devaiah, Anand K.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.02.2022
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background This study compares select social determinants of health (SDOH) with treatment modality selection and treatment completion in head and neck cancer (HNC) patients, to better understand disparities in health outcomes. Methods A retrospective cohort study of HNC (n = 1428) patients was conducted. Demographic and disease‐specific variables were recorded, including treatment modality selection and completion. Data were analyzed using two‐sample t tests, chi‐square, and Fisher's exact tests. Results Primary language was significantly associated with treatment choice, where non‐English speakers were less likely to choose treatment as recommended by the Tumor Board. Lower mean distance from the hospital (37.38 [48.31] vs. 16.92 [19.10], p < 0.0001) and a county‐based higher mean percentage of bachelor degree or higher education (42.16 [8.82] vs. 44.95 [6.19], p < 0.0003) were associated with treatment selection. Conclusion Language, distance from the hospital, and education affected treatment selection in this study and may be useful in understanding how to counsel patients on treatment selection for HNC.
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.26931